Foundation for Medical Advancement and Breakthroughs
FMAB is a non-profit foundation working alongside the innovative pioneers at BAMF Health to make precision medicine accessible and affordable as soon as possible. Donations are deployed to highly targeted initiatives and research that help us achieve tomorrow’s medical breakthroughs today.
Affordable Access As Soon As Possible
Your generous support saves lives. From providing financial resources to patients in need, to facilitating community education, to funding advanced research, every dollar makes a difference.
Patient Access
We provide financial assistance to patients who are struggling with insurance coverage, co-pays, travel expenses, or other barriers to access.
Education
We offer community education, student training programs, and workforce development opportunities to increase awareness of and advance the field of Theranostics.
Research
We advance the development and use of radiopharmaceuticals and further precision medicine.
More About Our Mission
Ways to Give
There are a variety of ways you, your family, and your loved ones can support the work happening at BAMF Health.
Donate Online
Make a donation at any time through our online donation portal. If your donation is in memory of a loved one, let us know by emailing us at foundation@bamfhealth.com with your name and the name of your loved one.
Donate by mail
Checks can be made payable to FMAB and mailed to:
Foundation for Medical Advancement and Breakthroughs
109 Michigan St. NW
Suite 700
Grand Rapids, MI 49503
BAMF Health's Latest News
Living Fully After an Alzheimer’s Diagnosis: Sandy’s Story
Sandy is determined not to let her Alzheimer’s diagnosis impact the fullness and quality of her life.
June 10, 2026
Sentara, BAMF Health Establish Joint Venture for Groundbreaking Theranostics Program
Comprehensive program will focus on advanced diagnostics and highly personalized cancer treatments using radiopharmaceuticals.
May 28, 2026
Lung Cancer Patient is First in the World to Participate in New Therapy Trial
Angela is the first person in the world to participate in a new clinical trial exploring an investigational radiopharmaceutical therapy.
May 20, 2026